<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-ijms-21-09049">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Choi</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Tian</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Manohar</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Harraz</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>S.W.</given-names>
   </name>
   <name>
    <surname>Schroeder</surname>
    <given-names>F.C.</given-names>
   </name>
   <name>
    <surname>Snyder</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Klessig</surname>
    <given-names>D.F.</given-names>
   </name>
  </person-group>
  <article-title>Human GAPDH Is a Target of Aspirinâ€™s Primary Metabolite Salicylic Acid and Its Derivatives</article-title>
  <source>PLoS ONE</source>
  <year>2015</year>
  <volume>10</volume>
  <elocation-id>e0143447</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0143447</pub-id>
  <?supplied-pmid 26606248?>
  <pub-id pub-id-type="pmid">26606248</pub-id>
 </element-citation>
</ref>
